MétaCan
Menu
Back to cohort
Record W4407285808 · doi:10.1093/jcag/gwae059.161

A161 HEMOPEXIN TREATMENT ALLEVIATES COLITIS SEVERITY IN THE ABSENCE OF IL-22RA1 SIGNALING IN MICE

2025· article· en· W4407285808 on OpenAlexaffabout
Ayodeji S. Ajayi, Claire Gerkins, Thibault Cuisiniere, C.A. McCartney, T Maumy, Roy Hajjar, Manon Oliero, Gabriela Fragoso, Annie Calvé, Manuela M. Santos

Bibliographic record

VenueJournal of the Canadian Association of Gastroenterology · 2025
Typearticle
Languageen
FieldMedicine
TopicMicroscopic Colitis
Canadian institutionsCentre Hospitalier de l’Université de Montréal
Fundersnot available
KeywordsHemopexinColitisSignal transductionMedicineImmunologyChemistryCell biologyBiologyBiochemistryEnzyme

Abstract

fetched live from OpenAlex

Abstract Background Inflammatory bowel disease (IBD) is often defined by persistent intestinal epithelial inflammation, bleeding, and pain. It is one of the major risk factors for colorectal cancer (CRC). IBD’s pathogenesis is fundamentally characterized by the release of free luminal heme. Dietary heme induces intestinal dysbiosis and exacerbates colitis. Interleukin 22 (IL-22) is produced in the gut by immune cells, mainly innate lymphoid cell 3 (ILC3). It is known to induce a protective response mediated by hemopexin, a plasma heme scavenger produced in the liver that limits the availability of heme iron to microbes and suppresses bacterial growth. Aims To evaluate the protective role of IL-22 by the stimulation of hemopexin in a mouse model of acute colitis Methods To assess the effect of IL-22 on colitis, Il22ra1-/- and wild-type (Wt) mice on a C57BL/6 background were treated with 2.5% dextran sodium sulphate (DSS) in drinking water for 12 days to induce colitis, after which they were sacrificed. To reverse colitis severity with hemopexin, three groups of mice received 2.5% DSS in drinking water for 12 days. The treatment group (Il22ra1-/-) received an 15 mg/kg BW hemopexin injection intraperitoneally on day 7 of the DSS treatment, while the other two groups, Wt and Il22ra1-/-, received the vehicle (PBS). Results Il22ra1 -/- mice had significantly greater weight loss, higher disease activity index (DAI) score and shorter colon length on day 12 (endpoint) compared to the Wt mice. Significant increases in inflammatory markers such as lipocalin-2 (lcn-2), TNF-α and IL-6 were observed in Il22ra1-/- mice, contributing to their condition. Decreased fecal hemopexin and increased free luminal heme were observed in Il22ra1-/- mice compared to the Wt mice. Hemopexin administration reversed the disease severity by reducing DAI, inflammatory markers and increasing the colon length. Increased fecal hemopexin and reduced luminal heme were also observed in the Il22ra1-/- mice. Conclusions Hemopexin is present in the gut during colitis. The absence of Il-22ra1 enhances free luminal heme production, reduces hemopexin concentration in the gut, and aggravates colitis in mice. Hemopexin administration reduces free luminal heme in the gut, enhances hemopexin availability and alleviates colitis severity in mice. Funding Agencies CIHRUniversite de Montreal, CRCHUM, Institute du Cancer de Montreal

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame machine prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.

metaresearch head score (Codex)0.000
metaresearch head score (Gemma)0.000
Version: metacan-v3-hybrid-931329e0061cValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Bench or experimental · Consensus signal: Bench or experimental
GenreCandidate signal: Empirical · Consensus signal: Empirical
Teacher disagreement score0.003
Threshold uncertainty score0.010

Distilled classifier scores by category (both heads)

CategoryCodexGemma
Metaresearch0.0000.000
Meta-epidemiology (narrow)0.0010.000
Meta-epidemiology (broad)0.0010.001
Bibliometrics0.0010.000
Science and technology studies0.0000.001
Scholarly communication0.0010.001
Open science0.0010.000
Research integrity0.0010.003
Insufficient payload (model declined to judge)0.0030.001

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.009
GPT teacher head0.253
Teacher spread0.244 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designBench or experimental
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations0
Published2025
Admission routes2
Has abstractyes

Explore more

Same venueJournal of the Canadian Association of GastroenterologySame topicMicroscopic ColitisFrench-language works237,207